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Simian virus (SV40) T antigen shares many characteristics with adenovirus E1A which is known to induce apoptosis. To verify
the potential of SV40 T antigen-mediated apoptosis, we stably expressed T antigen in immortalized human epithelial cells (Z172
and HaCaT). We found that SV40 T antigen could directly cause apoptosis in 22–27% of these cells under normal growth condition
as measured by chromatin condensation and nucleosomal fragmentation. The apoptosis of HaCaT cells which contain mutant p53
suggests the p53-independent nature of T antigen-mediated apoptosis. T antigen-induced apoptosis was associated with
increased expression of c-Jun protein. Moreover, the overexpression of c-jun alone in these cells also induced apoptosis, indicating
that c-jun might play an important role in T antigen-induced apoptosis. © 1998 Academic Press
INTRODUCTION
Transforming protein encoded by simian virus 40
(SV40) large T antigen is thought to disrupt cellular
growth control by interacting with tumor suppresser
proteins, such as p53 and pRb, that normally function
to regulate cell growth (Fanning and Knippers, 1992;
Levine, 1990). The ability of T antigen to stimulate cell
growth reflects the release of a brake on cell prolifer-
ation normally imposed by these tumor suppressor
proteins. The N terminal domain of the SV40 T antigen
was recently reported to have the ability to bind to and
presumably act on pRb which normally complexes
with the cellular transcription factor—E2F. This inter-
action results in the release of E2F which then acti-
vates genes for cell proliferation. SV40 T antigen can
also bind to p53 and the interaction between T antigen
and p53 results in inactivation of p53 function. SV40 T
antigen has also been shown to inhibit p53-mediated
transcription regulation.
In addition to the capability to stimulate cell prolifera-
tion, recent reports also indicated that SV40 T antigen
may be involved in the apoptosis of cells. In transgenic
mice, SV40 T antigen induces premature apoptic mam-
mary gland involution during late pregnancy (Tzeng et al.,
1996) and apoptosis in preneoplastic lesions during tu-
mor growth (Allemand et al., 1995). SV40 T antigen fails
to protect cells against myc-mediated apoptosis (Lena-
han and Ozer, 1996). The exact role of T antigen in
apoptosis is not clear. However, the association between
apoptosis and adenovirus E1A protein has been well
characterized (for a review, Mymryk, 1996). A transform-
ing oncogene product, E1A protein of adenovirus which
can bind pRb protein has been shown to cause rat
fibroblast cells apoptosis by stabilizing p53 and elevating
the level of intracellular p53 (Debbas and White, 1993;
Lowe and Ruley, 1993). It has been proposed that cell
death results from conflicting cell growth signals pro-
vided by E1A protein, which stimulates cellular prolifer-
ation (for a review, Branton et al., 1985), and the elevated
level of p53, which suppresses cell cycle progression
(for a review, Mymryk, 1996). The E1B gene product of
adenovirus can bind and inactivate p53 and Bax, a down-
stream effector of p53 that can induce apoptosis, and
prevent E1A-induced apoptosis. It is proposed that
through the prevention of E1A-induced apoptosis, E1B
may prolong the survival of adenovirus-infected cells,
providing enough time for the replication and maturation
of adenovirus (for a review, Mymryk, 1996). The same
mechanism may be responsible for the requirement of
E1B in the transformation of cells by E1A.
Since SV40 T antigen has the same pRb binding func-
tion as adenovirus E1A protein, and both of them can
immortalize and transform many different cells (for a
review, Levine, 1990), it is conceivable to us that SV40 T
antigen may also contain the apoptosis-inducing capa-
bility as adenovirus E1A. To test this possibility, we di-
rectly introduced T antigen into in immortalized human
epithelial cells to observe the occurrence of apoptosis
and investigate the possible mechanisms of SV40 T
antigen-mediated apoptosis. We found that SV40 T anti-
gen itself could induce 22–27% apoptosis in these cells
under normal growth conditions. T antigen-mediated ap-
optosis was associated with increased expression of
c-Jun and occurred through a p53-independent pathway.
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RESULTS
SV40 T antigen-induced apoptosis
As described in the Introduction, E1A can induce ap-
optosis, and SV40 T antigen shares many characteristics
with E1A (for a review, Levine, 1990). To determine
whether T antigen can induce apoptosis, we introduced
T antigen gene into two immortalized human epithelial
cells (Z172 and HaCaT).
Z172 cells are HPV-16 DNA-immortalized human epithe-
lial cells and contain HPV-16 E6 and E7 open reading
frames (ORFs) and exhibit the features of carcinoma in situ
(CINIII) (Pecoraro et al., 1991). In this study, we isolated two
different single cell clones (S2 and S4) from Z172 cells. S2
and S4 cells were transfected with a temperature-sensitive
mutant T antigen DNA (tsT)–pZipSVtsa58U19 or the control
vector DNA–pZip.neo.SV(X) by a lipofectin method, respec-
tively. After neomycin selection for 3 weeks, at least 80
resistant clones were pooled and established and named
S2/U19 cells and S4/U19 cells for containing ts T antigen
DNA or S2/Z and S4/Z cells for containing the control vector
DNA. As shown in Fig. 1, S2/Z contained lower level of Neu
and higher level of cytokeratin, when compared with S4/Z
cells, indicating that these two cell populations differ. A high
level of T antigen was detected in S2/U19 and S4/U19 cells
by immunoblot analysis (Fig. 1) and located in the nucleus
of both S2/U19 (Fig. 3c) and S4/U19 cells (data not shown)
by immunoperoxidase assay.
The ts T antigen exerts wild-type T function at 35°C but
is inactive at 39°C (Tsao et al., 1995a,b). Hence, all
experiments in this study were performed at 35°C. Fig-
ure 2 shows that at 35°C, S2/U19 still maintained epi-
thelial-like morphology (Fig. 2c); however, S4/U19 cells
became more fibroblast-like morphology (Fig. 2d). In ad-
dition, some giant cells were evident in both T antigen-
containing cells, S2/U19 and S4/U19 (Figs. 2c and 2d,
arrow), but not in the control cells, S2/Z and S4/Z (Figs.
2a and 2b). Growth curves of the control cells and T
antigen-containing cells were performed by counting cell
number daily with a hemocytometer. The results showed
FIG. 1. Analysis of Neu, cytokeratin, and T antigen protein levels in
cells. Cellular proteins were extracted from S2/Z, S2/U19, S4/Z, and
S4/U19 cells, and 100-mg proteins were then separated by a SDS–
PAGE gel and subjected to immunoblot analysis using antibodies
recognizing Neu, cytokeratin, and T antigen. S2/Z and S4/Z indicate
cells with the control vector, pZip.neo.SV(X) DNA; S2/U19 and S4/U19
indicate cells with T antigen DNA.
FIG. 2. Cell morphology of Z172 cells containing temperature-sensitive mutant SV40 T cultured at 35°C. Cells were plated at 35°C for 2 days and
then observed with Olympus IMT.2 phase contrast microscope. Magnification, 3250. Arrow, giant cells shown in T antigen-containing cells (c and
d). (a and b) S2/Z and S4/Z cells; (c and d) S2/U19 and S4/U19 cells, respectively.
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that the growth rate of the control cells (S2/Z, S4/Z) was
not different from that of SV40 T antigen-transfected cells
(S2/U19, S4/U19) (data not shown).
We then studied these cells for apoptosis. Cells con-
taining SV40 T antigen were stained with acridine orange
and visualized using a fluorescent microscope; both
S2/U19 and S4/U19 cells showed characteristic changes
of apoptosis such as chromatin condensation and nu-
clear fragmentation (Fig. 3d). The prevalence rates of
nuclear fragmentation in S2/U19 and S4/U19 cells were
22 and 27%, respectively, in contrast to 2 and 3% of the
control S2/Z and S4/Z cells (Table 1). This indicates that
SV40 T antigen promotes apoptosis. We also assayed for
DNA fragmentation, another characteristic of apoptosis
(Canman and Kastan, 1995), to confirm that these T
antigen-transfected cells were undergoing apoptosis.
Low molecular weight DNA was isolated from each cell
clone including detached and adherent cells after cells
were plated for 2 days. Nucleosome degradation of DNA
could be detected in both S2/U19 and S4/U19 cells (Fig.
4). Altogether, our results suggest that SV40 T antigen
itself can contribute apoptosis under the normal growth
conditions.
Z172 cells contain HPV-16 E6 and E7 genes. We there-
fore tested if T antigen can induce apoptosis in the
absence of these other oncogenes. We introduced SV40
T antigen gene into HaCaT cells which are a spontane-
ously immortalized human epithelial cell lines that do not
contain HPV E6 and/or E7 DNA (Boukamp et al., 1988).
Consistent with the results seen in the Z172 cells, T
antigen induced apoptosis in 25% of the HaCaT cells
(Table 1) as measured by DNA fragmentation (Fig. 5a)
and chromatin condensation (Fig. 5B,b). Thus SV40 T
antigen can induce apoptosis independent of HPV E6
and E7. In addition, HaCaT cells contain mutant p53
(Scheffner et al., 1991); hence T antigen-mediated apo-
ptosis, at least in this cells, may be through a p53-
independent pathway.
Effect of Bcl-2 on T antigen-mediated apoptosis
It has been reported that Bcl-2 protects some cells
from apoptosis and appears to be down-regulated by
wild-type p53 (Oltavi et al., 1993). Bcl-2 protein was un-
detectable in S2/U19 and S4/U19 cells (Fig. 6), indicating
that SV40 T antigen does not induce the expression of
bcl-2 gene. To understand whether Bcl-2 protein could
protect these two cells from apoptosis, we introduced
the bcl-2 gene into S2/U19 and S4/U19 by a lipofectin
method at 35°C. After 3 weeks, hygromycin-resistant
cells were established and named S2/U19/bcl2 and S4/
U19/bcl2 cells, respectively. Both cell populations ex-
pressed high levels of Bcl-2 protein (Fig. 6). Both S2/U19/
bcl2 and S4/U19/bcl2 cells contained the characteristics
of cell death such as chromatin condensation (Table 1)
and DNA ladder pattern (Fig. 4). Thus T antigen-mediated
apoptosis is independent of bcl-2. Bax has been reported
to accelerate apoptotic death induced by some stimuli
(Oltavi et al., 1993). The presence of Bax appears to
counter the death repressor activity of Bcl-2. It has been
proposed that the ratio of Bcl-2 to Bax determines sur-
vival or death following an apoptotic stimulus. High lev-
els of Bax protein were found in S2 and S4 cells with or
without T antigen. This may account for why Bcl-2 did not
prevent T antigen-mediated apoptosis in these cells.
T antigen-mediated apoptosis is associated with the
expression of c-Jun
c-jun has been shown to induce in both cell prolifer-
ation and apoptosis (Ryder and Nathans, 1988; Chen et
al., 1995; Bossy-Wetzel et al., 1997; Colotta et al., 1992).
Similarly, it was reported that cells undergo apoptosis
upon activation of c-myc under conditions of growth
factor deprivation (Lenahan and Ozer, 1996). To identify
the mechanism involved in T antigen-mediated apopto-
sis, we looked at the expression of c-jun and c-myc. As
shown in Fig. 7A, S2/U19, S4/U19, and HaCaT/U19 con-
tained high levels of c-Jun protein, but the concentrations
of c-Myc protein in S2/U19, S4/U19, and HaCaT/U19 cells
were the same as their control cells (S2/Z, S4/Z, HaCaT/
Z). This suggests that SV40 T antigen-mediated apopto-
sis might be associated with increased expression of
c-Jun protein, but not c-Myc protein. The levels of c-jun
mRNA in these T antigen-containing cells were mea-
sured by Northern blot. Figure 7B shows that RNA tran-
scripts in T antigen-containing cells were the same as in
the control cells (S2/Z, S4/Z, HaCaT/Z). Similarly T anti-
gen did not activate c-jun promoter activity in luciferase
reporter gene assay (data not shown). These observa-
tions suggest that T antigen alters c-Jun protein levels at
a posttranscription level.
The apoptosis-inducing potential capability of c-Jun
was explored by introducing the c-jun-expressing plas-
mid pC-jun (Tsao et al., 1996) or the control vector pCEP4
DNA (Invitrogen) into S2, S4, and HaCaT cells separately
and selecting transfectants with 200 mg/ml hygromycin.
After more than 3 weeks of selection, we failed to get any
c-jun-overexpressing cell clones. On the other hand,
more than 100 hygromycin-resistant clones presented in
the cells with pCEP4 vector DNA. As shown in Fig. 8,
after 1 week of selection, c-jun-containing cells acquired
the morphological changes of apoptosis such as bleb-
bing of cytoplasm and detaching from culture surface
(Fig. 8c); c-Jun protein was predominantly accumulated
in the nucleus of apoptotic cells (Fig. 8d, arrow). Figures
8a and 8b show the morphology and the expression of
c-Jun of the control cells with the vector DNA, respec-
tively. This is the first report that direct overexpression of
c-jun gene in immortalized human epithelial cells can
induce apoptosis.
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DISCUSSION
In this study, we demonstrate that SV40 T antigen
could promote apoptosis in immortalized human epithe-
lial cells under normal growth conditions. The conclusion
that T antigen-induced apoptosis is based on the induc-
tion of nuclear condensation and DNA fragmentation by
T antigen in cells. Previously, several reports demon-
strated that SV40 T antigen may be involved in the apo-
ptosis process under specific conditions. For example, T
antigen can potentiate c-myc-induced apoptosis in rat
fibroblast under the condition of serum deprivation (Jat
and Sharp, 1989). Apoptosis during mammary tumor pro-
gression was also reported in transgenic mice express-
ing the SV40 large T antigen. In this tumor development
model, apoptosis is frequently observed in preneoplastic
lesions and seldom observed in cells of carcinomas.
This implied that preneoplastic cells maintain the ability
to undergo apoptosis as a mechanism of tumor growth
suppression, and such critical control of apoptosis is lost
as these lesions progress to carcinomas (Allemand et
al., 1995; Shibata et al., 1996). SV40 T antigen has also
been shown to induce premature apoptotic mammary
gland involution during late pregnancy in transgenic
mice (Tzeng et al., 1996). Our findings demonstrated the
direct effect of T antigen in inducing apoptosis under cell
culture conditions. The transforming ability of SV40 T
antigen involves multiple domains; one domain (residues
1–120) binds to pRb and the other (residues 325–625)
binds to p53 (for a review, Fanning and Knippers, 1992).
We are currently investigating which domain(s) is re-
sponsible for apoptosis by using defined T antigen mu-
tant alleles.
Apoptosis can be induced through a p53-dependent or
-independent pathway (Shen and Shenk, 1995; Canman
and Kastan, 1995). It was reported that the adenovirus
E1A-induced apoptosis is through a p53-dependent
pathway (for a review, Mymryk, 1996). Here, we demon-
strated that T antigen-mediated apoptosis is p53 inde-
pendent. The strongest evidence supporting a p53-inde-
pendent mechanism is that T antigen-induced apoptosis
in HaCaT cells, which contain mutant p53 (Scheffner et
al., 1991). The involvement of SV40 T antigen in apoptosis
has been explored previously focusing on the ability of T
antigen to prevent apoptosis (McCarthy et al., 1994).
Thymocytes from transgenic mice expressing a T anti-
gen variant capable of binding to p53 are resistant to
FIG. 3. Expression of SV40 T antigen is associated with cell apoptosis. S2/Z and S2/U19 cells were fixed and stained with SV40 T antibody by
immunoperoxidase assay (a and c) and observed under microscope. The same cells were also stained with acridine orange (b and d) and observed
under fluorescent microscope. S2/Z and S2/U19 cells were described in the legend to Fig. 1.
FIG. 8. Overexpression of c-jun gene causes apoptosis in S2 cells. The c-jun expression vector (pC-jun, 5 mg) and vector control plasmid (pCEP4,
5 mg) were transfected into S2 cells, respectively, and cells were selected with 200 mg/ml hygromycin for 1 week. Cells containing c-jun gene blebbed
and detached from culture surface which are the characteristic changes of apoptosis (c). (a and c) The morphology of cells with the pCEP4 vector
DNA and pc-Jun DNA, respectively. (b and d) Cells with vector DNA or pc-Jun DNA were fixed and stained with c-Jun antibody by immunoperoxidase
assay respectively. Arrows, c-Jun protein predominantly located in the nucleus of cells containing c-jun gene.
TABLE 1
Apoptosis Index in Cells Containing SV40 T Antigen
Cell lines Apoptosis index (%)a
S2/Z 2.75 6 0.96b
S2/U19 22.40 6 2.07*
S2/U19/bcl2 25.50 6 1.73*
S4/Z 3.00 6 0.82
S4/U19 27.40 6 4.62*
S4/U19/bcl2 33.00 6 4.16*
HaCaT/Z 2.50 6 0.78
HaCaT/U19 25.40 6 1.36*
a Cells were stained with acridine orange and visualized using a
fluorescent microscope. Apoptotic index was the percentage of cells
that showed chromatin condensation and nuclear fragmentation.
b Values are means 6 SD. Apoptosis index was determined from five
repeats of experiments.
* Significant difference between levels in the control cells and T
antigen-containing cells. P , 0.01.
FIG. 4. DNA fragmentation assays. Low-molecular-weight DNA was
harvested from attached and detached cells, S2/Z, S2/U19, S2/U19/
bcl2, S4/Z, S4/U19, and S4/U19/bcl2 after being plated for 2 days, and
then analyzed by electrophoresis on a 1% agarose gel. S2/Z, S2/U19,
S4/Z, and S4/U19 cells were described in the legend to Fig. 1. S2/U19/
bcl2 and S4/U19/bcl2 cells were S2/19 and S4/U19 cells transfected
with bcl-2 gene, respectively.
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irradiation-induced apoptosis. However, thymocytes
from transgenic mice expressing a mutant T antigen
defective for p53 binding are sensitive to irradiation-
induced apoptosis which is p53 dependent. It also re-
ported that p53-dependent but not p53-independent ap-
optosis can be impaired by T antigen (McCarthy et al.,
1994). Whether T antigen variant capable of binding to
p53 induces or facilitates apoptosis of thymocytes was
not addressed in their observations. However, their ob-
servations do confirm that T antigen does not perturb a
p53-independent apoptosis. This is compatible with our
findings that T antigen may induce apoptosis through a
p53-independent pathway.
Our study showed that T antigen caused apoptosis in
HPV-16 E6, E7-positive cells (Z172 cells) and HPV-nega-
tive cells (HaCaT cells). E7 protein of HPV-16 shares
some characteristics with adenovirus E1A and SV40 T
antigen; all three can bind to and inactivate the tumor
suppresser pRb (Scheffner et al., 1990). On the other
hand, E6 protein like SV40 T antigen and adenovirus E1B
can bind to and inactivate p53. Thus, our results indicate
that SV40 T antigen alone can induce apoptosis inde-
FIG. 5. Apoptosis analysis in HaCaT cells expressing SV40 T antigen. (A) DNA fragmentation assay as described in the legend to Fig. 4. HaCaT/U19
and HaCaT/Z cells represent HaCaT cells with T antigen DNA and control vector DNA–pZip.neo.SV(X) DNA, respectively. (B) Cells were stained with
acridine orange and observed under a fluorescent microscope. (a) HaCaT/Z cells; (b) HaCaT/U19 cells.
FIG. 6. Analysis of Bcl2 and Bax protein concentrations in cells.
Equal amounts of proteins (100 mg) from S2/Z, S2/U19, S2/U19/bcl2,
S4/Z, S4/U19, and S4/U19/bcl2 cells were analyzed by SDS–PAGE.
Immunoblots using antibodies recognizing Bcl2 and Bax were per-
formed as described under Materials and Methods.
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pendent of HPV E6 and E7, which may have synergistic
effects but are not required.
In this study, we demonstrated that the mechanism of
T antigen-mediated apoptosis is associated with in-
creased expression of c-Jun which must be regulated at
a posttranscriptional level, but was not associated with
changes in bcl-2, c-myc, and neu gene expression. In
addition, we also find that, when directly introduced into
these human epithealial cells with c-jun gene could in-
duce apoptosis (Fig. 8). The c-jun gene is an immediate
early gene of a large series of signals involved in prolif-
eration, differentiation, and functional activation (Ryder
and Nathans, 1988; Colotta et al., 1992; Chen and Faller,
1995). The importance of c-jun gene induction in the
promotion of apoptosis has been reported. For example,
the c-jun gene is activated in the process of apoptotic
cell death caused by growth factor deprivation (Colotta et
al., 1992), tumor necrosis factora (TNF-a), and ultraviolet
light (Gupta and Davis, 1994; Suda et al., 1993). More-
over, it has been reported that treatment with a c-jun
antisense oligonucleotide inhibits apoptotic cell death of
lymphoid cells induced by growth factor deprivation (co-
lotta et al., 1992). In addition, c-Jun N-terminal kinase I
(JNK1), known to phosphorylate c-Jun, is also activated in
cells treated with growth factors or a potent inducer of
apoptosis (TNF-a, irradiation) (Chen et al., 1996). A recent
report further demonstrated that increased c-Jun activity
is sufficient to trigger apoptic cell death in NIH 3T3
fibroblasts (Bossy-Wetzel et al., 1997).
In our study, overexpression of bcl-2 could not protect
cells from SV40 T antigen-mediated apoptosis (Table 1).
There are two explanations. First, the cells we used
contain high amounts of Bax proteins. It has been sug-
gested that Bcl-2 itself is not the critical factor for the
decision of apoptosis of cells; of greater importance is
the ratio of Bcl-2 to Bax, a gene product which encodes
a dominant inhibitor of Bcl-2 (Oltavi et al., 1993). Second,
it has been reported that Bcl-2 prevents apoptosis of the
cells which are facing a stress or death challenge, but
not the cells which grow under normal growth conditions
(Chen and Faller, 1995). This suggests that the apoptosis
of cells under normal growth condition is bcl-2 indepen-
dent. In our studies, Bcl-2 could not prevent apoptosis,
perhaps because SV40 T antigen-mediated apoptosis in
cells is under normal growth conditions.
There was no change of the growth rate between T
antigen-containing ells and the control cells (data not
shown). Thus, the high incidence of apoptosis in the T
antigen-expressing cells (Table 1) must be counterbal-
ances by a higher cell division rate in T antigen-contain-
ing cells. This indicates that T antigen functions both as
growth promoter and as apoptosis inducer, and the fate
of individual cell depends on the balance of these two
functions. A similar conclusion was derived from obser-
vations made in T antigen transgenic animals where
tumor formation was accompanied by little apoptosis
whereas tumor regression was associated with signifi-
cant apoptosis (Shibata et al., 1996, Tzeng et al., 1996).
We postulate that factors decide the final fate of T anti-
gen-expressing cells must affect the growth regulatory
mechanisms downstream of T antigen. Other than T
antigen, c-Jun has also been shown to stimulate cell
growth and induce apoptosis (Ryder and Nathans, 1988;
Colotta et al., 1992). Our finding that c-Jun levels were
increased in T antigen-expressing cells suggests the
possibility that a mechanism deciding the role of growth
promotion and apoptosis may be common to T antigen
and c-Jun.
Taken together, our results demonstrate that SV40 T
antigen could contribute apoptosis under normal growth
condition. Although T antigen shares some similar char-
acteristics with adenovirus E1A, it had been reported by
several groups that E1A causes apoptosis through p53-
dependent pathway or neu-dependent pathway (Frisch,
1991). In contrast, the mechanism of T antigen-mediated
apoptosis in our system was a p53-independent pathway
and associated with the expression of c-Jun, but not
associated with Bcl-2, c-Myc, and Neu proteins. Overex-
FIG. 7. Analysis of c-Jun and c-Myc proteins by immunoblot and c-jun
RNA by Northern blot. (A) Cellular proteins were analyzed by immuno-
blot analysis as described above. (B) RNA (20 mg) of S2/Z, S2/U19, S4/Z,
S4/U19, HaCaT/Z, and HaCaT/U19 cells was fractionated by agarose
gel electrophoresis, blotted, and hybridized with 32P-labeled c-jun and
b-actin cDNA, separately. A b-actin probe was used to ensure equal
RNA loading.
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pression of c-jun gene in these human epithelial cell
lines could induce apoptosis.
MATERIALS AND METHODS
Cell culture and transfection
The immortalized human epithelial cells used for
studying T antigen-mediated apoptosis were Z172 (Pec-
oraro et al., 1991) and HaCaT cells (Boukamp et al.,
1988). Z172 cells, which are HPV-16 DNA-immortalized
human epithelial cells and the derived cells (S2 and S4
cells), were maintained in Dulbecco modified Eagle’s
medium (DMEM) supplemented with 10% NuIV serum
(Collaborative Research) and antibiotics. S2 and S4 cells
represent two different single clones from Z172 cells and
were transfected with pZipSVtsa58U19 plasmid DNA
(kindly provided by Dr. Philip A. Sharp) or the control
vector DNA–pZip.neo.SV(X) (kindly provided by Dr. R. C.
Mulligan) by a lipofectin method (Life Technologies,
Gaithersburg, MD). G418-resistant colonies (400 mg/ml)
were pooled, and named S2/U19 and S4/U19, which had
received the ts T antigen plasmid–pZipSVtsa58U19; or
S2/Z and S4/Z, which had received the the control vector
DNA–pZip.neo.SV(X). The bcl-2 gene cloned in the vector
pCEP4 (Invitrogen) was introduced into S2/U19 and S4/
U19, respectively, and then S2/U19/bcl2 and S4/U19/bcl2
cells were selected by growth in hygromycin (300 mg/ml)
for 3 or 4 weeks.
HaCaT cells, which are a spontaneously immortal-
ized human epithelial cells and do not have HPV
genome, were maintained in DMEM with 10% fetal calf
serum and antibiotics (Boukamp et al., 1988). Like-
wise, transfectant cells, HaCaT/U19 and HaCaT/Z,
were transfected with pZipSVtsa58U19 plasmid DNA
and the vector DNA, respectively, and selected under
G418 as described previously.
Acridine orange staining
Cells were fixed with ice-cold 75% ethanol and then
washed with phosphate-buffered saline (PBS) three
times. Cells were then permeabilized with PBS contain-
ing 0.1% Triton X-100 at room temperature for 30 min and
were stained with 10 mg/ml acridine orange (Sigma, St.
Louis, MO) in PBS for 30 min. Cells were then washed
with PBS and observed under fluorescent microscope
using blue filter.
Detection of DNA fragmentation in agarose gels
DNA extraction was performed by lysed cells in a
solution containing 0.5% SDS, 100 mM EDTA, 10 mM
Tris–HCl (pH 8.0), 20 mg/ml RNase, and 100 mg/ml pro-
teinase K and incubated at 37°C for 1 h with gentle
shaking. The suspension of lysate was then extracted
twice with phenol/chloroform and DNA was precipitated
with ethanol. DNA was electrophoresed on a 1% agarose
gel. The gel was stained with ethidium bromide and
photographed under UV light.
Northern blot hybridization
Total cytoplasmic RNA was prepared from cell lines
and analyzed by Northern blot hybridization. Filters were
washed to remove nonspecifically bound probe and then
air-dried and exposed to Kodak XAR film with Dupont
Lightning-plus intensification screens.
Immunoblots
Cellular proteins were extracted in sodium dodecyl
sulfate–polyacrylamide gel electrophoresis (SDS–PAGE)
loading buffer. After boiling for 10 min, about 100 mg of
each crude protein lysate was separated by SDS–PAGE,
transferred to nitrocellulose filters, reacted with specific
antibodies, and visualized by the enhanced chemilumi-
nescence system (Amersham, UK) using procedures rec-
ommended by manufacturer. Antibodies recognizing p53,
c-Myc, Bcl-2, and Bax were purchased from PharMingen
(San Diego, CA), and SV40 T antigen, c-Jun, and Neu
protein were from Oncogene Science.
Immunoperoxidase assays
For immunoperoxidase assays, cells in chamber
slides were rinsed with PBS for 10 s and fixed in cold
absolute ethanol for 2 min. The avidin–biotin method was
performed as described by the manufacturer with the
SV40 T or c-Jun antibody (Oncogene Science). Methylene
blue was the counterstain.
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